Published in Diabetes Care on January 01, 1999
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA (2002) 6.61
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med (2003) 5.87
Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med (2007) 4.65
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol (2008) 3.83
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology (2008) 3.37
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA (2015) 3.33
Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care (2012) 3.24
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care (2010) 3.20
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes (2009) 3.16
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care (2006) 2.64
Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population. Int J Epidemiol (2008) 2.59
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. N Engl J Med (2017) 2.56
Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia (2010) 2.19
Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev (2015) 2.19
Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care (2010) 2.08
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care (2014) 2.04
Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes (2009) 1.99
Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort. Diabetes Care (2009) 1.87
Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man. Diabetes (2011) 1.77
Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes (2010) 1.73
T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med (2010) 1.68
Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences. J Magn Reson Imaging (2011) 1.59
Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial. Diabetes Care (2008) 1.58
Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology (2009) 1.55
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care (2012) 1.55
Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst (2009) 1.52
Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care (2009) 1.52
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.42
Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes Care (2013) 1.39
Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr (2010) 1.35
Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.33
Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes (2013) 1.31
Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One (2009) 1.28
Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy? Diabetes Care (2007) 1.25
Pancreatic islet transplantation. PLoS Med (2004) 1.21
Comparison of intuitiveness, ease of use, and preference in two insulin pens. J Diabetes Sci Technol (2009) 1.20
Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation (2011) 1.20
DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep (2010) 1.18
Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes. Diabetes (2010) 1.18
Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes (2014) 1.17
Stratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectiveness. Diabetes Care (2013) 1.15
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Care (2016) 1.11
Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J Urol (2011) 1.10
Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. Am J Respir Crit Care Med (2012) 1.09
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions. Diabetes Care (2014) 1.07
The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort. Diabetes Care (2013) 1.07
The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord (2012) 1.06
Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care (2010) 1.05
Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus. Int J Gen Med (2011) 1.04
Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes. J Clin Endocrinol Metab (2008) 1.01
Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). J Am Coll Cardiol (2012) 1.00
Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Technol Ther (2013) 1.00
GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia (2014) 0.97
Vascular memory: can we broaden the concept of the metabolic memory? Cardiovasc Diabetol (2012) 0.97
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes. Nephrol Dial Transplant (2011) 0.97
Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC. Diabetes (2013) 0.96
The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care (2007) 0.95
Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus. Clin Trials (2012) 0.95
Intensive diabetes therapy and ocular surgery in type 1 diabetes. N Engl J Med (2015) 0.94
The Diabetes Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol (2009) 0.94
Effect of systemic medications on onset and progression of diabetic retinopathy. Nat Rev Endocrinol (2010) 0.94
Aortic distensibility in type 1 diabetes. Diabetes Care (2013) 0.93
Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes. J Med Genet (2010) 0.92
Urinary incontinence among women with type 1 diabetes--how common is it? J Urol (2009) 0.91
Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Clin J Am Soc Nephrol (2010) 0.91
The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study. Diabetes Care (2013) 0.91
Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus. Gastroenterology (2015) 0.90
Process of care compliance is associated with fewer diabetes complications. Am J Manag Care (2014) 0.89
Streptozotocin-induced diabetes modulates GABA receptor activity of rat retinal neurons. Exp Eye Res (2007) 0.89
Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences. J Diabetes Res (2017) 0.88
Bioenergetics in diabetic neuropathy: what we need to know. J Peripher Nerv Syst (2012) 0.88
Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes (2013) 0.88
Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort. Diabetes Care (2015) 0.87
Diabetes and the heart: is there objective evidence of a human diabetic cardiomyopathy? Diabetes (2013) 0.86
Musculoskeletal complications in type 1 diabetes. Diabetes Care (2014) 0.86
LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes. Atherosclerosis (2006) 0.86
Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes. Atherosclerosis (2010) 0.86
Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy. Ophthalmology (2013) 0.85
Higher normal ranges of urine albumin-to-creatinine ratio are independently associated with carotid intima-media thickness. Cardiovasc Diabetol (2012) 0.85
The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome. BMC Nephrol (2013) 0.85
Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep (2014) 0.85
Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial. Diabetes Care (2007) 0.84
Common genetic variants in selected Ca²⁺ signaling genes and the risk of appropriate ICD interventions in patients with heart failure. J Interv Card Electrophysiol (2013) 0.84
Intra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes. Diabetes Care (2007) 0.84
Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. World J Diabetes (2015) 0.83
Risk Factors for Cardiovascular Disease in Type 1 Diabetes. Diabetes (2016) 0.83
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Longitudinal data analysis for discrete and continuous outcomes. Biometrics (1986) 60.93
Random-effects models for longitudinal data. Biometrics (1982) 54.17
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 11.37
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol (1986) 6.27
Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia (1989) 5.68
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care (1994) 5.02
Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol (1995) 4.83
Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia (1983) 4.48
Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int (1995) 4.35
Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol (1987) 4.27
The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med (1995) 3.71
A proportional hazards model for interval-censored failure time data. Biometrics (1986) 3.64
Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia (1978) 3.40
A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med (1995) 3.17
Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes (1990) 3.07
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1989) 2.59
Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes (1997) 2.33
High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. The ARIC Study Group. J Neuroimaging (1991) 1.85
Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol (1990) 1.79
Anthropometric reference data and prevalence of overweight, United States, 1976-80. Vital Health Stat 11 (1987) 1.76
LONGEVITY OF DIABETIC PATIENTS IN RECENT YEARS. Diabetes (1965) 1.71
Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes (1982) 1.53
Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care (1986) 1.48
Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ (1990) 1.45
Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 1.44
Estimators and tests in the analysis of multiple nonindependent 2 x 2 tables with partially missing observations. Biometrics (1988) 1.44
Clinical measurement of systolic pressures in limbs with arterial occlusive disease. JAMA (1969) 1.44
Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia (1987) 1.41
Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes (1996) 1.39
Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes (1989) 1.18
The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med (1991) 1.12
Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med (1985) 1.10
Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia (1992) 1.08
Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes (1992) 1.08
Problems of repeated significance testing. Control Clin Trials (1981) 1.02
Cardiac function and coronary arteriography in asymptomatic type 1 (insulin-dependent) diabetic patients: evidence for a specific diabetic heart disease. Diabetologia (1986) 1.00
Prediction of coronary artery disease in a population of insulin-requiring diabetic patients: results of an 8-year follow-up study. Am Heart J (1988) 0.93
Extension of clinical trials. 10 1/2 year follow-up of the Multiple Risk Factor Intervention Trial. Circulation (1990) 0.91
Coronary artery surgery study revisited. Limitation of the intent-to-treat principle. Circulation (1990) 0.91
Exercise tests in male diabetics. A nine years' follow-up study with special reference to ECG changes and cardiovascular morbidity. Acta Med Scand Suppl (1977) 0.90
Association between retinopathy and impaired peripheral arterial circulation in insulin-dependent diabetic patients. Arteriosclerosis (1988) 0.90